News
12-10-2009, 11:20 PM
Genomic Health, Inc. today announced that The Lancet Oncology published positive results from a study of Oncotype DX(®) in postmenopausal women with node-positive, estrogen receptor-positive breast cancer conducted by the Southwest Oncology Group (SWOG), a National Cancer Institute-supported clinical trials cooperative group.
More... (http://www.news-medical.net/news/20091211/Positive-results-from-Genomic-Healths-Oncotype-DX-study-in-breast-cancer-patients-with-node-positive-disease.aspx)
More... (http://www.news-medical.net/news/20091211/Positive-results-from-Genomic-Healths-Oncotype-DX-study-in-breast-cancer-patients-with-node-positive-disease.aspx)